CHLORPHENIRAMINE POLISTIREX

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

13 API Suppliers, 6 USDMF, 1 CEP/COS, 4 EU WC, 3 KDMF, 3 NDC API, 8 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

22 FDF Dossiers, 14 FDA Orange Book, 2 Europe, 3 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION, EXTENDED RELEASE;ORAL - EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION, EXTENDED RELEASE;ORAL - EQ 2.8MG BASE/5ML;EQ 14.7MG BASE/5ML, SYRUP;ORAL - 2MG/5ML

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc, 3 SPI Pharma, 4 DKSH, 2 Pharm-RX Chemical, 7 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 6 Actylis, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 BASF, 1 Bioplus Life Sciences, 4 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 19 Kerry, 10 Microlex e.U, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 18 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

49 Fillers, Diluents & Binders, 26 Direct Compression, 20 Thickeners and Stabilizers, 16 Disintegrants & Superdisintegrants, 15 Co-Processed Excipients, 14 Film Formers & Plasticizers, 13 Granulation, 12 Taste Masking, 12 Lubricants & Glidants, 10 Coating Systems & Additives, 8 Parenteral, 7 Controlled & Modified Release, 7 Chewable & Orodispersible Aids, 6 Solubilizers, 6 Topical, 4 Emulsifying Agents, 3 Rheology Modifiers, 3 API Stability Enhancers, 1 Soft Gelatin